MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment

被引：0
|
作者：
Xiaoyue Xu
Shaorong Yu
Wenbo Sun
Xiaobing Qin
Yan Chen
Leilei Zhou
Rui Lou
Shuchen Dong
Bo Shen
Jianzhong Wu
Jialan Zang
Haixia Cao
Meiqi Shi
Qin Zhang
Jifeng Feng
机构：
[1] Jiangsu Institute of Cancer Research,Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital
[2] Nanjing Medical University Affiliated Brain Hospital,Department of Neurosurgery
[3] Xuzhou First People’s Hospital,Department of Oncology, Huai’an First People’s Hospital
[4] Nanjing Medical University,Department of Oncology
[5] The First Hospital of Harbin City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
Lung adenocarcinoma; MiRNA; Platinum resistance; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 438
页数：7
相关论文
共 50 条
  • [21] Impact of Platinum/Pemetrexed versus Other Platinum-Based Regimens on Adjuvant Chemotherapy in Resected Adenocarcinoma Lung Cancer
    Zhai, Xiaoyu
    Wang Ziping
    Yang, Lu
    Zhu, Yixiang
    Li, Junling
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S930 - S931
  • [22] Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy
    Fang, Chao
    Li, Xiang-Ping
    Gong, Wei-Jing
    Wu, Na-Yiyuan
    Tang, Jie
    Yin, Ji-Ye
    Li, Xi
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 : 21 - 29
  • [23] An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
    Zhou, Yuan
    Tang, Lu
    Chen, Yuqiao
    Zhang, Youyu
    Zhuang, Wei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [24] A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma
    Gao, Xinliang
    Tang, Mingbo
    Tian, Suyan
    Li, Jialin
    Liu, Wei
    FUTURE ONCOLOGY, 2021, 17 (12) : 1533 - 1544
  • [25] MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients
    Dhara M MacDermed
    Nikolai N Khodarev
    Sean P Pitroda
    Darrin C Edwards
    Charles A Pelizzari
    Lei Huang
    Donald W Kufe
    Ralph R Weichselbaum
    BMC Medical Genomics, 3
  • [26] Targeting ALDH2 to augment platinum-based chemosensitivity through ferroptosis in lung adenocarcinoma
    Shan, Guangyao
    Bian, Yunyi
    Yao, Guangyu
    Liang, Jiaqi
    Shi, Haochun
    Hu, Zhengyang
    Zheng, Zhaolin
    Bi, Guoshu
    Fan, Hong
    Zhan, Cheng
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 224 : 310 - 324
  • [27] A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
    Chang, Qing-Hua
    Zhang, Yuan-Cui
    Zhang, Dong-Ying
    Mao, Ting
    Chang, Ran
    Wang, Nan
    Ye, Yun
    Xu, Zi-Jun
    AGING-US, 2023, 15 (09): : 3498 - 3523
  • [28] Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
    Sun, Zihao
    Chen, Xiujing
    Huang, Xiaoning
    Wu, Yanfen
    Shao, Lijuan
    Zhou, Suna
    Zheng, Zhu
    Lin, Yiguang
    Chen, Size
    LIFE-BASEL, 2023, 13 (07):
  • [29] A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
    Tang, Xiaolong
    Qi, Chumei
    Zhou, Honghong
    Liu, Yongshuo
    HELIYON, 2022, 8 (08)
  • [30] Eight-gene signature predicts recurrence in lung adenocarcinoma
    Zhang, Yongjian
    Fan, Qiang
    Guo, Yingying
    Zhu, Koujun
    CANCER BIOMARKERS, 2020, 28 (04) : 447 - 457
12345